-+ 0.00%
-+ 0.00%
-+ 0.00%

IONIS PARTNER BIOGEN PRESENTS PHASE 2 CELIA DATA AT AAIC DEMONSTRATING MEANINGFUL CLINICAL OUTCOMES AND ROBUST TAU REDUCTION WITH DIRANERSEN IN EARLY ALZHEIMER’S DISEASE

Reuters·07/14/2026 13:16:00

Please log in to view news